Studies suggested age [25, 63], biological factors (e.g., higher blood pressure, serum albumin), comorbidities (cardiovascular disease, diabetes) and medication use (e.g.; more frequent use of calcitriol and less use of statins in African-Americans compared to Caucasians) [43, 63] may partly explain ethnic differences in survival for African-Americans/Afro-Caribbeans and Caucasians with CKD. The gene discussed is ALB; the disease is cardiovascular disorder.